Biogen Inc. 8-K Filing: Key Updates & Insights (May 6, 2025)

Based on the provided section of the financial report, here are the key insights and information extracted:

1. Entity Information:

• Company Name: Biogen Inc.
• CIK (Central Index Key): 0000875045
• SEC File Number: 0-19311
• IRS Employer Identification Number (EIN): 33-0112644
• Address: 225 Binney Street, Cambridge, MA 02142
• Phone Number: (617) 679-2000

2. Security Information:

• Type of Security: Common Stock
• Par Value: $0.0005
• Ticker Symbol: BIIB
• Exchange: NASDAQ

3. Filing Type:

• Form Type: 8-K (This form is used to report major events that shareholders should know about.)

4. Reporting Period:

• Filing Date: May 6, 2025
• Reporting Period: The report covers the date May 6, 2025.

5. XML and XBRL Structure:

• The document is structured in XML format and complies with XBRL (eXtensible Business Reporting Language), which is used for financial reporting.

6. Schema Reference:

• The filing references a schema file named "biib-20250506.xsd," indicating the format and structure of the data within this report.

Summary

This section provides essential information about Biogen Inc.'s filing with the SEC, including identification details, security information, and the nature of the report. The use of an 8-K form suggests that there may be significant updates or events relevant to investors. The filing is dated May 6, 2025, and is structured using XBRL for standardized reporting.